Skip to content

Clinical trials

Phase 1 Opioid-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Phase: Phase 1 Clear all

148 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20083
20091
20106
20117
20126
20135
20142
20156
20164
20178
20188
20196
20208
20217
202211
202313
202410
20257
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96
Recruiting17
Terminated11
Unknown status8
Withdrawn6
Not yet recruiting5
Active, not recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)22
Yale University8
Indivior Inc.7
USWM, LLC (dba US WorldMeds)5
Medical University of South Carolina4
Pfizer4
University of California, San Francisco4
AstraZeneca3
Johns Hopkins University3
New York State Psychiatric Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders148
Chronic Pain14
Substance-Related Disorders13
Pain7
Acute Pain4
Anxiety Disorders4
Postoperative Pain4
Cocaine-Related Disorders3
Drug Overdose3
Marijuana Abuse3

Trials

Showing 51 to 75 of 148. Each trial links to its page on Pharma Observatory.

48 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.